Bayer Aktienges ADR (OP: BAYRY )
7.810
+0.130
(+1.69%)
Streaming Delayed Price
Updated: 3:59 PM EDT, Aug 23, 2024
Add to My Watchlist
Headline News about Bayer Aktienges ADR
![](https://cdn.pixabay.com/photo/2017/08/26/10/47/businessman-2682712__340.jpg)
![](https://cdn.benzinga.com/files/images/story/2024/01/11/aapharma_0.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2024/01/08/bayer_ag_cross_2005.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2024/bz-pharma-briefs.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2024/Congress-Trading-Shutterstock.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/12/26/bayer_us-roundup-ready-to-use-weed-and-grass-killer-iii-iii-main-5200210-xxl_0.png?width=1200&height=800&fit=crop)
Legal Victory For Bayer: Roundup Lawsuit Ends Five-Trial Losing Streak
December 26, 2023
Via Benzinga
Topics
Lawsuit
![](https://cdn.benzinga.com/files/images/story/2023/Esg-Concept-Of-Environmental--Social-And.jpeg?width=1200&height=800&fit=crop)
ESG Stocks Take Center Stage As Damages From Climate-Related Events Rise Exponentially Within US
December 19, 2023
Via Benzinga
Topics
Climate Change
Exposures
Climate
![](https://investorplace.com/wp-content/uploads/2023/02/ai-artificial-intelligence-pen-chart-1600.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/12/06/gavel-_image_by_succo_from_pixabay-.jpg?width=1200&height=800&fit=crop)
Bayer Faces $3.5M Verdict in Fifth Consecutive Roundup Weedkiller Loss
December 06, 2023
Via Benzinga
Exposures
Glyphosate
![](https://cdn.benzinga.com/files/images/story/2023/12/04/bayer_co.png?width=1200&height=800&fit=crop)
Bayer Faces Growing Pressure Amid Roundup Lawsuits as Philadelphia Trial Nears Conclusion
December 04, 2023
Via Benzinga
Topics
Lawsuit
![](https://cdn.benzinga.com/files/images/story/2023/chemicals-shutter.jpeg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2019/07/blue-chip-closeup.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/11/24/bayer.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/11/20/bmy_3.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/11/20/bayer.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/11/17/mrk.png?width=1200&height=800&fit=crop)
Bayer's Legal Victory Against Merck: Delaware Court Rules In Company's Favor Regarding Talc Lawsuits
November 17, 2023
Via Benzinga
Topics
Lawsuit
![](https://cdn.benzinga.com/files/images/story/2023/11/08/aapharma_2.png?width=1200&height=800&fit=crop)
![](https://tokenist.com/wp-content/uploads/2023/11/57703747_m_normal_none-646x360.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/11/01/bayer_us-roundup-ready-to-use-weed-and-grass-killer-iii-iii-main-5200210-xxl_0.png?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2022/03/cathie-wood-stocks-1600.png)
![](https://cdn.benzinga.com/files/female-scientist-lab-with-notepad.jpg?width=1200&height=800&fit=crop)
AI To Revolutionize Clinical Trials And Diagnostics
September 22, 2023
Via Benzinga
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
![](https://cdn.benzinga.com/files/images/story/2023/09/22/laboratory-g420324b5c_1920.jpg?width=1200&height=800&fit=crop)
From Years to Months: How AI is Shaping the Landscape of Clinical Trials
September 22, 2023
Via Benzinga
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
![](https://cdn.benzinga.com/files/images/story/2023/09/12/pill-_image_by_arek_socha_from_pixabay_.jpg?width=1200&height=800&fit=crop)
FDA Panel Says Popular OTC Cold, Allergy Medicine Might Be Useless - Stocks To Watch
September 12, 2023
Via Benzinga
Exposures
Product Safety
![](https://cdn.benzinga.com/files/images/story/2023/08/28/china_money-938269_1920.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/08/28/aapharma_1.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/08/21/aapharma.png?width=1200&height=800&fit=crop)
FDA Approves Regeneron Pharmaceuticals' Higher Dose Of Eylea For Age-Related Blindness
August 21, 2023
Via Benzinga
Exposures
Product Safety
![](https://cdn.benzinga.com/files/images/story/2023/08/08/screenshot_2023-08-08_at_5.41.13_pm.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/07/31/regn.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/07/17/screenshot_2023-07-17_at_5.33.51_pm.png?width=1200&height=800&fit=crop)
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.